Meta-analysis of artificial pancreas trials: methodological considerations

The Lancet Diabetes and Endocrinology

Volumn 5, Issue 9, 2017, Pages 685-

  Bekiari, Eleni ^a   Karagiannis, Thomas ^a   Haidich, Anna Bettina ^a   Tsapas, Apostolos ^a,b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ARTIFICIAL PANCREAS; BIOSENSOR; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INTERVENTION STUDY; LETTER; NORMAL DISTRIBUTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SYSTEMATIC REVIEW; META ANALYSIS (TOPIC);

HUMANS; META-ANALYSIS AS TOPIC; PANCREAS, ARTIFICIAL;

EID: 85028324720     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(17)30261-9     Document Type: Letter

References (4)

1. Weisman, A, Bai, J-W, Cardinez, M, Kramer, CK, Perkins, BA, Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials. Lancet Diabetes Endocrinol 5 (2017), 501–512.
2. 7.7.3.5 Medians and interquartile ranges. Higgins, JPT, Green, S, (eds.) Cochrane handbook for systematic reviews of interventions, version 5.1.0, 2011, Cochrane Collaboration.
3. Scherer, RW, Langenberg, P, von Elm, E, Full publication of results initially presented in abstracts. Cochrane Database Syst Rev, 2, 2007, MR000005.
4. Golder, S, Loke, YK, Wright, K, Norman, G, Reporting of adverse events in published and unpublished studies of health care interventions: a systematic review. PLoS Med, 13, 2016, e1002127.